| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
2',3'-dideoxycytidinene
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: 2',3'-unsaturated derivative of 2',3'-dideoxycytidine; potent inhibitor of HTLV-III in vitro; structure given in first source
Also Known As:2',3'-DDDC; 2',3'-didehydro-2',3'-dideoxycytidine; 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine; 2',3'-dideoxy-2',3'-didehydrocytidinene; 2',3'-dideoxy-2',3-didehydrocytidine; ddeCyd
Bio-Agent Context: Research Results
Related Diseases
| 1. | HIV Infections (HIV Infection)
06/01/1987
- "In this report, we demonstrate the antiviral effect of nucleoside analogs 2',3'-didehydro-2',3'-dideoxythymidine (DHT) and 2',3'-didehydro-2',3'-dideoxycytidine (DHC) by using human T-cell lymphotropic virus type I-carrying MT-4 cells, which are extremely susceptible to HIV infection"
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |